未找到相关数据
Trastuzumab-reactive antibodies (TR-abs) in serum and trastuzumab (Tzb) benefit prediction in patients with HER2-overexpressing breast cancer
被引：1
作者：
Pohlmann, Paula Raffin
Miller, Todd W.
Blum, David L.
Pareh, Dipti
Yan, Heping
Sutton, Cammie R.
Dugger, Teresa C.
Salazar, Lupe G.
Wu, William
Reyzer, Michelle L.
Disis, Mary L.
Mernaugh, Ray
Arteaga, Carlos L.
机构：
[1] Vanderbilt Univ, Nashville, TN 37235 USA
[2] Dartmouth Coll, Hanover, NH 03755 USA
[3] Dept Biochem & Mol Biol, Athens, GA USA
[4] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[5] Washington Univ, St Louis, MO USA
[6] Univ Washington, Seattle, WA 98195 USA
关键词：
D O I：
10.1200/jco.2012.30.30_suppl.77
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
77
引用
收藏
页数：1
相关论文